Moderna reiterated its full-year 2025 product sales forecast of $1.5 billion to $2.5 billion, with most expected in the ...

Moderna Inc. said it will reduce annual spending by about $1.5 billion by 2027 as the company continues to cut costs to ...

The U.S. FDA is planning to require all new vaccines to undergo placebo-controlled trials before approval. Read more here.

After President Trump’s first nominee to lead the Centers for Disease Control and Prevention (CDC) failed to gain traction ...

COVID - 19: The Company reported $84 million in Spikevax® sales in the first quarter of 2025, which includes $29 million of U.S. sales and $55 million of international sales. As previously reported, ...

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

Health and Human Services Secretary Robert F. Kennedy Jr. intends to shift the way vaccines are tested, a move that the agency said will increase transparency but that medical experts fear could limit ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.